Prostate Cancer Foundation Appoints Executive to Oversee Discovery and Translational Research
Howard R. Soule, PhD, rejoins the PCF after two-year sabbatical to lead innovative research efforts

SANTA MONICA, Calif. — February 23, 2007 — The Prostate Cancer Foundation (PCF) has announced the appointment of Howard R. Soule, PhD as Executive Vice President, Discovery and Translation.

Dr. Soule brings several decades of research and healthcare experience to this new position and is responsible for coordinating global academic, government and biopharmaceutical research activities in prostate cancer. Central to this mission, Dr. Soule is charged with implementing the PCF’s global research strategies which are projected to grow exponentially under his new leadership.

"We are delighted to have Howard join the PCF at this new, exciting time," said Jonathan W. Simons, MD, Chief Executive Officer and President of the Prostate Cancer Foundation. "His extensive knowledge and background in global research and translational science pushes the PCF to new boundaries in the search for better treatments and a cure for prostate cancer."

"In this new role, Howard will be able to forge strategic alliances with academic, government and the biopharmaceutical industry while working closely with an extensive network of physician/researchers to benefit the two million men currently battling prostate cancer," said Michael Milken, Founder and Chairman of the Prostate Cancer Foundation. "We are excited to welcome him back to the PCF."

Distinguished researchers in the prostate cancer community echoed Milken’s sentiments.

"I am delighted that Howard will once again take an active role at the PCF," said Peter T. Scardino, MD, chair of the Department of Surgery at Memorial-Sloan Kettering Cancer Center. "He has a great sense of what needs to get done to push the prostate cancer research agenda to a new place."

"Howard has tremendous experience and knowledge in the field of prostate cancer research," said Robert H. Getzenberg, PhD, Donald S. Coffey Professor and Director of Research of the James Buchanan Brady Urological Institute and Professor of Urology at the Johns Hopkins University School of Medicine. "His track record of facilitating the movement of ideas to clinical practice makes him an outstanding person to work with during this exciting time."

About Howard Soule, PhD
Dr. Soule was Executive Vice President and Chief Science Officer at the PCF from 1997 to 2004. Most recently, he was Managing Director of Knowledge Universe Health and Wellness Group, a private investment firm focused on companies in the general areas of disease prevention and treatment.

Prior to joining the PCF in 1997, Dr. Soule was a senior research and development executive for nearly a decade at Corvas International, Inc., a public biotechnology company. He was responsible for the discovery and development of innovative products for the treatment of life-threatening cardiovascular diseases.

In addition, Dr. Soule has considerable experience in medical diagnostic and device industries. Dr. Soule received a PhD from Baylor College of Medicine in Virology and Epidemiology and was a Post Doctoral Fellow in Immunology and Vascular Biology at the Scripps Research Institute.

About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world's largest philanthropic source of support for prostate cancer research. Founded in 1993, the PCF has raised more than $288 million and provided funding for prostate cancer research to more than 1,200 researchers at 100 institutions worldwide. The PCF has a simple, yet urgent goal: to find better treatments and a cure for prostate cancer. For more information, visit www.prostatecancerfoundation.org.

Contacts:

Katie Lambe
(310) 570-4713
klambe@prostatecancerfoundation.org